Bioqual Statistics
Want to see BIOQ full AI Analyst Report?
Bioqual (BIOQ) Stock Statistics & Valuation Metrics
Total Valuation
Bioqual has a market cap or net worth of $27.04M. The enterprise value is $44.97M.
- Market Cap
- $27.04M
- Enterprise Value
- $44.97M
Share Statistics
Bioqual has 893,838 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 893,838
- Owned by Insiders
- ―
- Owned by Institutions
- 0.29%
Financial Efficiency
Bioqual’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -6.85%.
- Return on Equity (ROE)
- -0.13
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -6.85%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 143.70K
- Profits Per Employee
- -14.99K
- Employee Count
- 278
- Asset Turnover
- 0.58
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bioqual is -6.29. Bioqual’s PEG ratio is -0.01.
- PE Ratio
- -6.29
- PS Ratio
- 0.69
- PB Ratio
- 0.87
- Price to FCF
- -42.61
- Price to Operating Cash Flow
- -167.58
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Bioqual had revenue of 39.95M and earned -4.17M in profits. Earnings per share was -4.66.
- Revenue
- 39.95M
- Gross Profit
- 1.43M
- Operating Income
- -4.47M
- Pretax Income
- -3.72M
- Net Income
- -4.17M
- EBITDA
- -2.25M
- Earnings Per Share (EPS)
- -4.66
Cash Flow
In the last 12 months, operating cash flow was -165.45K and capital expenditures -485,228, giving a free cash flow of -650.68K billion.
- Operating Cash Flow
- -165.45K
- Free Cash Flow
- -650.68K
- Free Cash Flow per Share
- -0.73
Dividends & Yields
Bioqual pays an annual dividend of $0.50, resulting in a dividend yield of ―
- Dividend Per Share
- $0.50
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.35%
- Earnings Yield
- -15.92%
Stock Price Statistics
- Beta
- -0.18
- 52-Week Price Change
- -25.77%
- 50-Day Moving Average
- 33.03
- 200-Day Moving Average
- 34.73
- Relative Strength Index (RSI)
- 24.49
- Average Volume (3m)
- 557
Important Dates
Bioqual upcoming earnings date is Jan 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Jan 15, 2027
- Ex-Dividend Date
- Oct 07, 2024
Financial Position
Bioqual as a current ratio of 4.22, with Debt / Equity ratio of 100.93%
- Current Ratio
- 4.22
- Quick Ratio
- 4.22
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- -9.58
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Bioqual has paid 452.50K in taxes.
- Income Tax
- 452.50K
- Effective Tax Rate
- -0.12
Enterprise Valuation
Bioqual EV to EBITDA ratio is -30.96, with an EV/FCF ratio of -74.33.
- EV to Sales
- 1.20
- EV to EBITDA
- -30.96
- EV to Free Cash Flow
- -74.33
- EV to Operating Cash Flow
- -292.33
Balance Sheet
Bioqual has $16.47M in cash and marketable securities with $31.92M in debt, giving a net cash position of -$15.45M billion.
- Cash & Marketable Securities
- $16.47M
- Total Debt
- $31.92M
- Net Cash
- -$15.45M
- Net Cash Per Share
- -$17.28
- Tangible Book Value Per Share
- $34.57
Margins
Gross margin is 2.60%, with operating margin of -11.80%, and net profit margin of -10.97%.
- Gross Margin
- 2.60%
- Operating Margin
- -11.80%
- Pretax Margin
- -10.08%
- Net Profit Margin
- -10.97%
- EBITDA Margin
- -3.88%
- EBIT Margin
- -11.25%
Analyst Forecast
The average price target for Bioqual is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -14.30%
- EPS Growth Forecast
- -610.16%
Scores
- Smart Score
- ―
- AI Score
- 43
